News
Stopping JIA drugs? Many can regain control after a flare
About 67% of patients who stopped medications for well-controlled JIA got their condition under control by 1 year after postflare treatment,...
News
Devices to detect skin cancer: FDA advisers offer mixed views
There's been a swell in recent years in the number of publications related to the use of AI and machine learning, which could give rise to new...
News
FDA panel urges caution with skin cancer–detecting tools
The FDA called a meeting amid growing interest in using technology to aid in finding cancers, with some of these products already marketed to...
News
Scientists aim to combat COVID with a shot in the nose
The Biden administration held a summit on the future of COVID-19 vaccines.
News
Lawmakers argue for changes in prior authorization processes
Reports from a federal watchdog agency find patterns of denials of prior authorization requests of covered services by insurer-run Medicare...
News
FDA panel strongly backs protein-based Novavax COVID-19 vaccine
“Having a protein-based alternative may be more comfortable for some in terms of their acceptance of vaccines.”
News
FDA, AMA prepare for potential COVID-19 shots for children younger than 6
“We strongly urge all parents to get their infants and toddlers vaccinated as soon as they are eligible for a COVID-19 vaccine,” said AMA...
News
CDC panel lists reasons to get second COVID booster
One panelist said she was concerned about the potential for “booster fatigue.”
News
FDA, DEA pushed to make gabapentin a controlled substance to stop ‘widespread misuse’
There is “substantial evidence of widespread misuse” of gabapentin, plausibly helped by “extraordinary levels of off-label prescribing.”
News
Clozapine interrupted: APA, others seek FDA forum on REMS
Clozapine can decrease the neutrophil count, which can lead to severe neutropenia, serious infection, and death.
News
High praise, condemnation for CMS Aduhelm coverage plan
The drug clears amyloid in the brain, but that may or may not result in clinical benefit.
News
Biden’s FDA chief nominee narrowly wins Senate confirmation
Dr. Robert Califf returns to lead the FDA as the U.S. continues to cope with the pandemic and opioid epidemic.